Qol Medcl Drug Patent Portfolio
Qol Medcl owns 1 orange book drug protected by 3 US patents Given below is the list of Qol Medcl's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9255261 | Ultrapure hypoallergenic solutions of sacrosidase | 07 Feb, 2034 | Active |
| US9469847 | Ultrapure hypoallergenic solutions of sacrosidase | 07 Feb, 2034 | Active |
| US9849161 | Ultrapure hypoallergenic solutions of sacrosidase | 07 Feb, 2034 | Active |
Latest Legal Activities on Qol Medcl's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Qol Medcl.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Yr, Small Entity | 07 Mar, 2024 | US9469847 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 25 Jul, 2023 | US9255261 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 28 Jun, 2021 | US9849161 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 20 Apr, 2020 | US9469847 |
| Post Issue Communication - Certificate of Correction | 24 Feb, 2020 | US9255261 |
| Post Issue Communication - Certificate of Correction | 18 Feb, 2020 | US9469847 |
| Post Issue Communication - Certificate of Correction | 18 Feb, 2020 | US9849161 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 09 Aug, 2019 | US9255261 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 26 Dec, 2017 | US9849161 |
|
Recordation of Patent Grant Mailed
Critical
| 26 Dec, 2017 | US9849161 |
| Sequence Moved to Public Database | 26 Dec, 2017 | US9849161 |
|
Email Notification
Critical
| 07 Dec, 2017 | US9849161 |
|
Issue Notification Mailed
Critical
| 06 Dec, 2017 | US9849161 |
|
Application Is Considered Ready for Issue
Critical
| 20 Nov, 2017 | US9849161 |
| Dispatch to FDC | 20 Nov, 2017 | US9849161 |
Qol Medcl's Family Patents
Qol Medcl Drug List
Given below is the complete list of Qol Medcl's drugs and the patents protecting them.
1. Sucraid
Sucraid is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9255261 | Ultrapure hypoallergenic solutions of sacrosidase |
07 Feb, 2034
(9 years from now)
| Active |
| US9469847 | Ultrapure hypoallergenic solutions of sacrosidase |
07 Feb, 2034
(9 years from now)
| Active |
| US9849161 | Ultrapure hypoallergenic solutions of sacrosidase |
07 Feb, 2034
(9 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Sucraid's drug page